Sign in

CIK 0001709941

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

BioAge Labs, Inc.

Sign in to watch
Ticker
BIOA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474721157
Phone
+1 510-806-1445
Business address
5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA, 94608
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-17 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +110,000 110,000
2026-02-17 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +12,500 12,500
2025-02-18 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2025-02-18 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +200,000 200,000
2024-09-25 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +4,952 4,952
2024-04-17 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +257,973 257,973
2024-04-17 Morgen Eric Chief Operating Officer Grant or award · Stock Option (Right to Buy) +13,598 13,598

Page 1 of 1 · 7 trades